WAY-270360

CAS No. 476633-98-4

WAY-270360( N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide )

Catalog No. M28522 CAS No. 476633-98-4

WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 135 In Stock
10MG 188 In Stock
25MG 332 In Stock
50MG 456 In Stock
100MG 642 In Stock
200MG Get Quote In Stock
500MG 1274 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-270360
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    476633-98-4
  • Formula Weight
    373.412
  • Molecular Formula
    C22H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(C(=O)Nc2ccc(cc2)-c2nc3ccccc3[nH]2)c(OC)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JBJ-04-125-02

    JBJ-04-125-02 (0-1000 nM; 72 hours; H1975 cells) treatment could inhibit cell proliferation of H1975 cells at low nanomolar concentrations.

  • CP-380736

    CP-380736 is an epidermal growth factor receptor (EGFR) inhibitor. EGFR is a tyrosine kinase that activates MAPK, JNK, and Akt pathways, and is an important mediator of several types of cancer.

  • Selatinib

    Selatinib is an orally active and potent dual inhibitor of EGFR and ErbB2 with anticancer activity that inhibits the growth of NCI-N87 tumor cells.